Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 175 results for "leerink swann llc"

Leerink Swann Initiates Team Health Holdings At Outperform

Analysts at Leerink Swann initiated coverage on Team Health Holdings LLC (NYSE: TMH) with a Outperform rating. The target price for Team Health Holdings is set to $73. Team Health Holdings shares have jumped 38.98 percent over the past 52 weeks, ... Benzinga.com, 2 weeks ago
Mideast Time

Leerink Swann Boosts Inogen Price Target to $45.00 (INGN)

Inogen (NASDAQ:INGN) had its price objective hosited by Leerink Swann from $40.00 to $45.00 in a report released on Tuesday. Leerink Swann currently has an outperform rating on the stock. Other equities research analysts have also recently issued ...
 SleekMoney4 days ago Inogen Given New $45.00 Price Target at Leerink Swann (INGN)  WKRB News6 days ago Inogen PT Raised to $45.00 (INGN)  American Banking News6 days ago Leerink Swann Boosts Mallinckrodt PLC Price Target to $141.00 (MNK)  SleekMoney1 month ago
[x]  
SleekMoney

Leerink Swann Initiates Coverage on ACADIA Pharmaceuticals (ACAD)

Analysts at Leerink Swann started coverage on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) in a research report issued to clients and investors on Thursday, TheFlyOnTheWall.com reports. The firm set an outperform rating and a $48.00 price target ...
 SleekMoney2 weeks ago ACADIA Pharmaceuticals Coverage Initiated by Analysts at Leerink Swann (ACAD)  WKRB News2 weeks ago ACADIA Pharmaceuticals Now Covered by Leerink Swann (ACAD)  American Banking News2 weeks ago Bellerophon Therapeutics Coverage Initiated by Analysts at Leerink Swann (BLPH)  SleekMoney1 month ago
[x]  

Alnylam Pharmaceuticals Shares Up 3.3% After Analyst Upgrade (ALNY)

Alnylam Pharmaceuticals (NASDAQ:ALNY) shares rose 3.3% during mid-day trading on Tuesday after Leerink Swann raised their price target on the stock to $145.00, AmericanBankingNews.com reports. The company traded as high as $132.99 and last traded at ...
 SleekMoney1 week ago Alnylam Pharmaceuticals PT Raised to $145.00 (ALNY)  Ticker Report1 week ago Alnylam Pharmaceuticals Trading Down 7.8% After Insider Selling (ALNY)  SleekMoney1 week ago Paul Schimmel Sells 10,000 Shares of Alnylam Pharmaceuticals Stock (ALNY)  SleekMoney1 week ago

Boston Scientific Stock Rating Reaffirmed by Needham & Company LLC (BSX)

Boston Scientific (NYSE:BSX) s stock had its hold rating reissued by equities researchers at Needham & Company LLC in a research report issued on Wednesday. BSX has been the subject of a number of other recent research reports. Analysts at ...
 SleekMoney4 days ago Needham & Company LLC Reaffirms Hold Rating for Vertex Pharmaceuticals (VRTX)  SleekMoney4 days ago Vertex Pharmaceuticals Given Buy Rating at Canaccord Genuity (VRTX)  SleekMoney1 day ago Intercept Pharmaceuticals Given Buy Rating at Wedbush (ICPT)  SleekMoney1 week ago

Inogen PT Set at $46.00 by Needham & Company LLC (INGN)

Needham & Company LLC set a $46.00 price objective on shares of Inogen (NASDAQ:INGN) stock in a research note issued on Monday. The firm currently has a a strong-buy rating on the stock. Needham & Company LLC's price target would indicate a ...
 SleekMoney5 days ago Inogen Given a $46.00 Price Target at Needham & Company LLC (INGN)  Mideast Time6 days ago CONMED Given New $56.00 Price Target at Needham & Company LLC (CNMD)  SleekMoney1 week ago
SleekMoney

Jefferies Group LLC Begins Coverage on Heron Therapeutics (HRTX)

Jefferies Group LLC started coverage on shares of Heron Therapeutics (NASDAQ:HRTX) in a research note released on Friday morning. The firm issued a buy rating and a $22.00 target price on the stock. Jefferies Group LLC has also taken action a ...
 SleekMoney1 month ago Analysts Set Dyax Corp. PT at $27.69 (NASDAQ:DYAX)  SleekMoney1 week ago Recent Analysts Ratings Updates for Dyax Corp. (DYAX)  SleekMoney2 weeks ago Research Analysts Weekly Ratings Updates for Dyax Corp. (DYAX)  Ticker Report3 weeks ago
[x]  
American Banking News

Inogen Coverage Initiated by Analysts at Needham & Company LLC (INGN)

Needham & Company LLC began coverage on shares of Inogen (NASDAQ:INGN) in a report released on Thursday. The firm issued a strong-buy rating and a $45.00 price objective on the stock. Shares of Inogen ( NASDAQ:INGN ) opened at 36.71 on Thursday.
 SleekMoney2 weeks ago Inogen Now Covered by Needham & Company LLC (INGN)  American Banking News2 weeks ago

Cerulean Pharma major shareholder Acquires $1,999,998.00 in Stock (CERU)

Cerulean Pharma (NASDAQ:CERU) major shareholder Cvf, Llc purchased 333,333 shares of the stock on the open market in a transaction that occurred on Tuesday, April 7th. The shares were purchased at an average cost of $6.00 per share, with a total ...
 SleekMoney3 weeks ago Insider Buying: Cvf, Llc Acquires 333,333 Shares of Cerulean Pharma Stock (CERU)  WKRB News3 weeks ago
WKRB News

Needham & Company LLC Analysts Give Dyax Corp. a $30.00 Price Target (DYAX)

Needham & Company LLC set a $30.00 target price on Dyax Corp. (NASDAQ:DYAX) in a report issued on Wednesday. The firm currently has a a buy rating on the stock. Several other analysts have also recently commented on the stock. Analysts at Leerink ...
 WKRB News4 weeks ago Dyax Corp. Given a $30.00 Price Target at Needham & Company LLC (DYAX)  SleekMoney1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less